Pharmacotherapeutic agents in xenotransplantation

Expert Opinion on Pharmacotherapy

Volumn 1, Issue 4, 2000, Pages 757-769

  Basker, M ^a   Buhler, L ^a   Alwayn, Ipj ^a   Appel, J Z ^a   Cooper, D K C ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Anti gal antibodies; Antibodies; Disseminated intravascular coagulation; Macrophages; Medronate liposomes; Monoclonal antibodies; Thrombotic microangiopathy; Xenotransplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANIMAL; DISSEMINATED INTRAVASCULAR CLOTTING; GRAFT REJECTION; HETEROTOPIC TRANSPLANTATION; HUMAN; IMMUNOLOGY; PAPIO; REVIEW; SWINE; THROMBOSIS;

ANIMALS; DISSEMINATED INTRAVASCULAR COAGULATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PAPIO; SWINE; THROMBOSIS; TRANSPLANTATION, HETEROTOPIC;

EID: 0034189806     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.1.4.757     Document Type: Article

References (68)

1. Xenotransplantation - The Transplantation Of Organs And Tissues Between Species. (Edition 2). Cooper DKC, Kemp E, Platt JL, White DJG (Eds.), Springer, Heidelberg, Germany (1997).
2. Xeno - The Promise of Transplanting Animal Organs into Humans. Cooper DKC, Lanza RP (Eds.), Oxford University Press, New York, USA (2000). Review of all aspects of xenotransplantation for the general reader.
3. COOPER DKC, YE Y, ROLF IX JR, ZUHDI N: The pig as a potential organ donor for man. In: Xenotranplantation. Cooper DKC, Kemp E, Reemtsma K, White DJG (Eds.), Springer, Heidelberg, Germany (199D:481-500.
4. YE Y, NIEKRASZ M, KOSANKE S et al.: The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man. Transplantation (1994) 57:694-703.
5. SACHS DH: The pig as a potential xenograft donor. Vet. Immunol. Immunopatb. (1994) 43:185-191.
6. GOOD AH, COOPER DKC, MALCOLM AJ et al: Identification of carbohydrate structures that bind human anti-porcine antibodies: implications for discordant xenografting in humans. Transplant. Proc. (1992) 24:559-562. The first identification of the importance of anti-Gal antibodies in xenotransplantation.
7. ORIOL R, YE Y, KOREN E, COOPER DKC: Carbohydrate antigens of pig tissues reacting with human natural antibodies as potential targets for hyperacute vascular rejection in pig-to-man organ xenotransplantation. Transplantation (1993) 56:1433-1442.
8. COOPER DKC, KOREN E, ORIOL R: Oligosaccharides and discordant xenotransplantation. Immunol. Rev. (1994) 141:31-58.
9. SANDRIN MS, VAUGHAN HA, DABKOWSKI PL, MCKENZIE IFC: Anti-pig IgM antibodies in human serum react predominantly with Gal(l-3)Gal epitopes. PrOC. Katl. Acad. Sei. USA (1993) 90:11391.
10. GALILI U, CLARK MR, SHOHET SB, BUEHLER J, MACHER BA: Evolutionary relationship between the natural antiaGal antibody and the Galal-3Gal epitope in primates. Proc. Natl. Acad. Sei. USA (1987) 84:1369-1373.
11. COOPER DKC, HUMAN PA, LEXER G et al.: Effects of cyclosporin and antibody adsorption on pig cardiac xenograft survival in the baboon. / Heart Transplant. (1988) 7:238-246.
12. PERPER RJ, NAJARIAN JS: Experimental renal heterotransplantatlon. 1. In widely divergent species. Transplantation (1966) 4:377-388.
13. ROSE AG, COOPER DKC, HUMAN PA, REICHENSPURNER H, REICHART B: Histopathology of hyperacute rejection of the heart: experimental and clinical observations hi allografts and xenografts.J. Heart Lung Transplant. (1991) 10:223-234.
14. PLATT JL, .FISCHEL RJ, MATAS AJ et al.: Immunopathology of hyperacute xenograft rejection in a swineto-primatc model. Transplantation (1991) 52:214-220.
15. ALEXANDRE GPJ, GIANELLO P, LATINNE D et ah. Plasmapheresis and splcncctomy in experimental renal xenotransplantation. In: Xenograft 25. Hardy MA (Ed.), Eisevier, New York, USA (1989):259-266.
16. COOPER DKC, CAIRNS TDH, TAUBE DH: Extracorporeal immunoadsorption of anti-pig antibody in pigs using aGal oligosaccharide imniunoaffinity columns. Xcno (1996) 4:27-29.
17. XU Y, LORF T, SABLINSKI T et al.: Removal of anti-porcine natural antibodies from human and nonhuman primate plasma in vitro and in vivo by a GaIal-3Galpl-4Glc-X imniunoaffinity column. Transplantation (1998) 65:172-179.
18. KOZLOWSKI T, SHIMIZU A, LAMBRIGTS D et al: Porcine kidney and heart transplantation in baboons undergoing a tolerance inducing regimen and antibody adsorption. Transplantation (1999) 67:18-30.
19. LEVENTHAL JR, DALMASSO AP, CROMWELL JW et al.: Prolongation of cardiac xenograft survival by depletion of complement. Transplantation (1993) 55:857-865.
20. PRUITT SK, BOLLINGER RR, COLLINS BH et al.: Effect of continuous complement inhibition using soluble complement receptor Type 1 on- survival of pig-toprimate cardiac xenografts. Transplantation (1997) 63:900-902.
21. KOBAYASHI T, TANIGUCHI S, NEETHUNG FA et al.: Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation (1997) 64:1255-1261.
22. COZZIE, WHITE DJG: The generation of transgenic pigs as potential organ donors for humans. Nature Med. (1995) 1:964.
23. MCCURRY KR, KOOYMAN DL, ALVARADO CG et ah Human complement regulatory proteins protect swine to primate cardiac xenografts from human injury. Nature Med. 1995:1:423-427.
24. SCHMOECKEL M, BHATTI FN, ZAIDI A et al.: Orthotopic heart transplantation in a transgenic pig-to-primate model. Transplantation (1998) 65:1570-1507.
25. ZAIDI A, SCHMOECKEL M, BHATTI F et al.: life-supporting pig-to-prinia te renal xcnotransplantation using genetically modified donors. Transplantation (1998) 65:1584-1590. Illustrates current results that can be obtained with the use of hDAF pig organs transplanted into non-human primates.
26. BHATTI FN, SCHMOECKEL M, ZAIDI A et al.: Threemonth survival of hDAF transgenic pig hearts transplanted into primates. Transplant. Proc. (1999) 31:958.
27. LAMBRIGTS D, VAN CALSTER P, XU Y et ah Pharmacologie immunosuppressivc therapy and extracorporeal immunoadsorption in the suppression of antiaGal antibody in the baboon. Xenolransplantatlon (1998) 5:274-283.
28. LAMBRIGTS D, SACHS DH, COOPER DKC: Discordant organ xenotransplantation in primates. World experiencc and current status. Tranplantation (1998) 66:547-561. Comprehensive review of therapeutic approaches and results achieved in the pig-to-non-human primate model.
29. BACH FH, WINKLER H, FERRAN C, HANCOCK WW, ROBSON SC: Delayed xenograft rejection. Immunol. Today. (1996) 17:379-384. Description of factors involved in acute vascular xenograft rejection.
30. GOODMAN DL, MILLAN MT, FERRAN C et al.: Mechanisms of delayed xenograft rejection. In: Xenotransplantation - The Transplantation Of Organs And Tissues Between Species (Second Edition), Cooper DKC, Kemp E, Platt JL, White DJG (Eds.), Springer, Heidelberg, Germany (1997):77-94.
31. LIN SS, WEIDNER BC, BYRNE GW et al.: The role of antibodies in acute vascular rejection of pig-to-baboon cardiac transplants./ Clin. Invest. (1998) 101:1745-1756.
32. ALWAYN IPJ, BASKER M, BUHLER L, COOPER DKC: The problem of antiplg antibodies in pig-to-primate xenografting: current and novel methods of depletion and/or suppression of production of antipig antibodies. Xenotransplantation (1999) 6:157-168.
33. BUHLER L, AWWAD M, BASKER M et al.: High-dose porcine hematopoietic cell transplantation combined with CD40L blockade in baboons prevents an induced antipig humoral response. Transplantation (In Press). The first report demonstrating that co-stimulatory blockade with an anti-CD154 mAb prevents the induced humoral response in a large animal xenograft model.
34. IERINO FL, KOZLOWSKI T, SIEGEL JB et al.: Disseminated intravascular coagulation in association with the delayed rejection of pig-to-baboon renal xcnografts. Transplantation (1998) 66:1439-1450.
35. BUHLER L, BASKER M, ALWAYN IPJ et al.: Coagulation and thrombotic disorders associated with pig organ and hematopoietic cell transplantation hi nonhuman primates. Transplantation (In Press). Describes and discusses the thrombotic microangiopathy and DIG that can be associated with xenotransplantation.
36. KOPP GW, SIEGEL JB, HANCOCK WW et al.: Effect of porcine endothelial tissue factor pathway inhibitor on human coagulation factors. Transplantation (1997) 63:749-758
37. SAADI S, HOLZKNECHT RA, PATTE CP et al.: Complement regulation of tissue factor activity in endothelium.J. Exp. Meet. (1995) 182:1807-1814
38. ROBINSON LA, TU L, STEEBER DA et al.: The role of adhesion molecules hi human leukocyte attachment to porcine vascular endo t helium: implications for xenotransplantation./ Immunol. (1998) 161:6931-6938
39. KOPP CW, ROBSON SC, SIEGEL JB et al.: Regulation of monocyte tissue factor activity by allogeneic and xenogeneic endothelial cells. Thromb. Haemost. (1996) 79:529-538
40. YAMADA K, SACHS DH, DERSIMONIAN H: Human antiporcine xenogeneic T-cell response: evidence for allclic specificity of mixed leukocyte reaction and for both direct and indirect pathways of recognition. Immunol. (1995) 1550249-5256
41. YAMADA K, SEEBACH JD, DERSIMONIAN H, SACHS DH. Human an tipig T-cell mediated cytotoxicity. Xenolransplantation (1996) 3:179-187
42. CHAVEZ G, COZZI E, THIRU S et al: Pig to primate cellular xenograft rejection, a humoral independent process. Abstract presented at the 5th Congress of the International Xenotransplantation Association. Nagoya, Japan (1999).
43. LECHLER RI: Manipulating xenoreactive T-cells: Role of T-cell responses in rejection. Plenary session presented at the 5tb Congress of the International Xenotransplantation Association. Nagoya, Japan (1999).
44. SYKES M, SACHS DH: Xenogeneic tolerance through hematopoictic cell and thymic transplantation. In: Xenotraiisplantation - The Transplantation Of Organs And Tissues Between Species, (Second Edition). Cooper DKC, Kemp E, Platt JL, White DJG (Eds.), Springer, Heidelberg, Germany (1997):496-518. Excellent review of work attempting to induce tolerance to xenografts.
45. SACHS DH, SYKES M, GREENSTEIN JL, COSIMI AB: Tolerance and xenograft survival. Nature Med. (1995) 1:969.
46. BARTHOLOMEW AM, POWELSON J, SACHS DH et al: Tolerance in a concordant nonhuman primate model Transplantation (1999) 68:1709.
47. OHDAN H, YANG YG, SH1MIZU A et al.: Mixed chimerism induced without lethal conditioning prevents T-cell- and antiGal a l,3Gal-mediated graft rejection./ Clin. Invest. (1999) 104:281-290.
48. BRACYJL, SACHS DH, IACOMINI J: Inhibition of xenoreactivc natural antibody production by retroviral gene therapy. Science (1998) 281:1845-1847. First description of gene therapy to induce B-cell tolerance of relevance to xenotransplantation.
49. IERINO FL, GOJO S, BANERJEE PT etal: Transfer of swine major histocompatibility complex class II genes into autologous bone marrow cells of baboons for the induction of tolerance across xenogeneic barriers. Transplantation (1999) 67:1119-1128.
50. YAMADA K, SHIMIZU A, IERINO FL et al.: Thymic transplantation in miniature swine: 1. Development and function of the 'thymokidney'. Transplantation (1999) 68:1684-1692.
51. KAWAI T, COSIMI B, COLVIN R et al. Mixed allogeneic chimerism and renal allograft tolerance in cynomolgus monkeys. Transplantation (1995) 59:256-262.
52. SPITZER TR, DELMONICO F, TOLKOFF-RUBIN N et al.: Combined histocompatible leukocyte antigenmatched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohcmatopoictic chimerism. Transplantation (1999) 68:480-484. Report of patient in whom immunologie tolerance was induced following concomitant bone marrow and kidney transplantation from the same donor.
53. NASH K, CHANG Q, WATTS A et ah. Peripheral blood progenitor cell mobilization and Icukaphcrcsis In pigs. Lab. Anim. Sei. (1999) 49:645-649.
54. VAN ROOIJEN N, SANDERS A. Liposome mediated depiction of macrophages: mechanism of action, preparation of liposomes and applications./ Immunol. Methods (1994) 174: 83-93
55. BUHLER L, GOEPFERT M, KITAMURA H et al: Porcine hematopoictic cell xenotransplantation in nonhuman primates is complicated by a thrombotic microangiopathy. (Submitted).
56. ALWAYN IP), APPEL JZ III, GOEPFERT C, BUHLER L, COOPER DKC, ROBSON SC: Inhibition of platelet aggregation in baboons: therapeutic implications for xenotransplantation. (Submitted).
57. COOPER DKC, KOREN E, ORIOL R: Genetically engineered pigs [letter]. Lancet (1993) 342:682-683.
58. OSMAN N, MCKENZIE IF, OSTENRIED K et al.: Combined transgcnic expression of a-galactosidase and a 1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Gala (1,3) GaL Proc. Natl. Acad. Sei. USA (1997) 94:14677-14682.
59. SHINKEL TA, CHEN CG, SALVARIS E et al.: Changes In cell surface gh/cosylatlon in a 1,3-galactosyltransferase knockout and a 1,2-fucosyltransferase transgenic mice. Transplantation (1997) 64:197-204.
60. SANDRIN MS, FODOR WL, MOUHTOURIS E et al.: Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nature Med. (1995) 1:1261-1267.
61. CHEN D, RIESBECK K, KEMBALL-COOK G et al.: Inhibition of tissue factor-dependent and-independent coagulation by cell surface expression of novel anticoagulant fusion proteins. Transplantation (1999) 67:467-474
62. ALEXANDRE GPJ, SQUIFFLET JP, DE BRUYERE M et al.: Present experience in a series of 26 abo-incompatible living donor renal allografts. Transplant. Proc. (1987) 19:4538.
63. BACH FH, PLATT J, COOPER DKC: Accommodation - the role of natural antibody and complement in discordant xenograft rejection. In: Xenotranplantation. Cooper DKC, Kemp E, Reemtsma K, White DJG (Eds.), Springer, Heidelberg, Germany (1990:81-99.
64. BACH FH, TURMAN MA, VERCELLOTTI GM, PLATT JL, DALMASSO AP: Accommodation: a working paradigm for progressing toward clinical discordant xenografting. Transplant. Proc. (1991) 23:205-207.
65. TANEMURA M, MARUYAMA S, GALILI U: Differential expression of a-GAL cpitopes (Galal-3Gall-4GlcNAc-R) on pig and mouse organs. Transplantation (2000) 69:187-190.
66. TANEMURA M, YIN D, CHONG AS, GALILIU: Differential immune responses to cc-gal epitopes on xcnografts and allografts: implications for accommodation in xenotransplantation. J. Clin. Invest. (2000) 105:301-310. Interesting studies on factors influencing success or failure of achieving accommodation of allografts and xenografts.
67. LACHMANN PJ, HALBWACHS L: The influence of c3b iiiactivator (kaf) concentration on the ability of serum to support complement activation. Clin. Exp. Jmmunol. (1975) 21:109-114.
68. COOPER DKC: Xenoantigens and xcnoantibodics. Xenotransplantation (1998) 5:6-17.